RiboX Therapeutics
PrivateLast Round
VC Round
Jul 5, 2022
Company Overview
RiboX Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a VC Round in July 2022.
RiboX Therapeutics is a biotechnology company that focuses on the discovery and development of fully engineered circular RNA therapeutics, a new class of RNA medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RiboX Therapeutics Comparables
Compare RiboX Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CirCode Biomedicine | 87% | |
| Therorna Inc. | 86% | |
| Eli Lilly and Company | 84% |
For institutional investors. Book with your work email.
RiboX Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
RiboX Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | VC Round |
| Boehringer Ingelheim | VC Round |
| Eisai Innovation | VC Round |
| Lilly Asia Ventures | VC Round |
| Qiming Venture Partners | VC Round |
| Vivo Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2022
$110M raised from Boehringer Ingelheim Venture Fund, Eisai Innovation, and Temasek.
For institutional investors. Book with your work email.
RiboX Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RiboX Therapeutics's valuation, stock price, and market status.
Is RiboX Therapeutics a public or private company?
RiboX Therapeutics is a private company.
What is the current stock price of RiboX Therapeutics?
RiboX Therapeutics is a private company, so its shares have no public market price. Caplight tracks RiboX Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RiboX Therapeutics worth (valuation)?
Valuation information for RiboX Therapeutics is not publicly available.
Can I buy RiboX Therapeutics stock?
RiboX Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RiboX Therapeutics's last funding round?
RiboX Therapeutics's most recent funding round was VC Round on July 5, 2022.
Who are the main investors in RiboX Therapeutics?
Key investors in RiboX Therapeutics include Temasek, Boehringer Ingelheim, Eisai Innovation, Lilly Asia Ventures, Qiming Venture Partners.
Will RiboX Therapeutics IPO soon?
No public IPO plans have been announced for RiboX Therapeutics.
How can I track RiboX Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in RiboX Therapeutics's shares on secondary markets.